Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study
Launched by CHRISTOPH ARNOLDNER · Nov 16, 2018
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how cochlear implants can help patients regain hearing after they have had Gamma Knife radiosurgery for vestibular schwannoma, a type of tumor that can affect hearing. The study involves measuring brain responses related to hearing before and during the surgery to better understand how well the cochlear implant works afterward.
To participate in this study, you need to be between 65 and 74 years old and have previously undergone radiosurgery for vestibular schwannoma. If you are interested in getting a cochlear implant to improve your hearing, you might be a good fit for the trial. Participants will undergo some tests before and during the surgery, and the results will be compared to see how well the cochlear implant helps with hearing after the procedure. If you decide to join, you will play an important role in helping researchers learn more about this treatment option.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who have undergone radio surgery for vestibular schwannoma
- • Patients wanting cochlear implantation for hearing rehabilitation
- Exclusion Criteria:
- • Patients not wanting to participate in the study
About Christoph Arnoldner
Christoph Arnoldner is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and innovation. With a focus on enhancing patient outcomes, he leads initiatives that prioritize rigorous scientific methodologies and ethical standards in clinical trials. His expertise encompasses a broad range of therapeutic areas, ensuring that each study is designed to generate meaningful data that contributes to the development of safe and effective treatments. Christoph’s collaborative approach fosters partnerships with healthcare professionals, regulatory bodies, and research institutions, driving progress in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials